Thermo Fisher Scientific (TMO) FY2022 results: revenue $44.9 billion, up 14.5% on the year
Thermo Fisher Scientific Inc. (TMO) reported revenue of $44.9 billion for fiscal 2022, the year ended 31 December 2022, up 14.5% on the year before. Net income was $7.0 billion, down 10.0%, and diluted earnings per share $17.63. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2023.
Revenue
$44.9 billion
+14.5% on the year
FY2015FY2022
Operating margin
18.7%
25.6% a year earlier
FY2015FY2022
Net income
$7.0 billion
-10.0% on the year
FY2015FY2022
Diluted EPS
$17.63
-9.4% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
9,154
9,312
8,289
-1.7%
Capital expenditure
2,243
2,523
1,474
-11.1%
Free cash flow
6,911
6,789
6,815
+1.8%
Free cash flow margin
15.4%
17.3%
21.2%
Cash from investing
-2,159
-21,932
-1,510
Cash from financing
-2,810
6,581
959
Depreciation and amortisation
3,381
2,592
2,325
+30.4%
Share-based compensation
307
230
196
+33.5%
Buybacks
3,000
2,000
1,500
+50.0%
Dividends paid
455
395
337
+15.2%
Dividend per share
$1.20
$1.04
$0.88
+15.4%
Diluted shares, weighted
394m
397m
399m
-0.8%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
43,978
40,793
34,507
+7.8%
Non-controlling interest
54.0
62.0
10.0
-12.9%
Redeemable equity
116
122
0.0
-4.9%
Debt
34,488
34,870
21,735
-1.1%
Operating lease liabilities
1,313
1,203
626
+9.1%
Other liabilities
17,205
18,073
12,174
-4.8%
Total liabilities and equity
97,154
95,123
69,052
+2.1%
Fixed assets
9,280
8,333
5,912
+11.4%
Goodwill
41,196
41,924
26,041
-1.7%
Intangible assets
17,442
20,113
12,685
-13.3%
Cash and equivalents
8,524
4,477
10,325
+90.4%
Receivables
8,115
7,977
5,741
+1.7%
Inventory
5,634
5,051
4,029
+11.5%
Other assets
6,963
7,248
4,319
-3.9%
Total assets
97,154
95,123
69,052
+2.1%
10-K for the year ended 31 December 2022, filed 23 February 2023: the filing.